enVVeno Medical (NVNO) Beginning Cash Balance (2017 - 2018)
enVVeno Medical's quarterly Beginning Cash Balance came in at -$9136.0 in Q2 2018, down 107.03% quarter-over-quarter from $130000.0 in Q1 2018.
enVVeno Medical has reported Beginning Cash Balance for 2 years, with the latest figure at -$9136.0 in Q2 2018.
- For the quarter ending Q2 2018, Beginning Cash Balance changed N/A year-over-year to -$9136.0; the trailing twelve-month figure through Dec 2018 stood at $120864.0 (changed N/A YoY), and the FY2018 full-year result was $120864.0, down 30.83% from the prior year.
- Beginning Cash Balance for Q2 2018 stood at -$9136.0, down from $130000.0 in the prior quarter.
- The five-year high for Beginning Cash Balance was $130000.0 in Q1 2018, with the low at -$9136.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | enVVeno Medical | 6.99 Mn | 6.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -9,136.00 |
| Jun 30, 2018 | -9,136.00 |
| Mar 31, 2018 | 130,000.00 |
| Mar 31, 2018 | 130,000.00 |
| Sep 30, 2017 | 86,882.00 |
| Sep 30, 2017 | 86,882.00 |